These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Rhenium-188 microspheres: a new radiation synovectomy agent. Wang SJ; Lin WY; Chen MN; Hsieh BT; Shen LH; Tsai ZT; Ting G; Chen JT; Ho WL; Mirzadeh S; Knapp FF Nucl Med Commun; 1998 May; 19(5):427-33. PubMed ID: 9853331 [TBL] [Abstract][Full Text] [Related]
6. Rhenium-188 sulphur colloid as a radiation synovectomy agent. Wang SJ; Lin WY; Hsieh BT; Shen LH; Tsai ZT; Ting G; Knapp FF Eur J Nucl Med; 1995 Jun; 22(6):505-7. PubMed ID: 7556293 [TBL] [Abstract][Full Text] [Related]
7. [Preliminarily experimental study on biological properties of 153Sm-citrate-nano-Hydroxyapatite]. Wen GH; Deng HF; Bing WZ; Luo SZ Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):1017-20. PubMed ID: 18095611 [TBL] [Abstract][Full Text] [Related]
8. Preparation and pre-clinical study of 177Lu-labelled hydroxyapatite for application in radiation synovectomy of small joints. Abbasi I; Ishfaq M; Sohaib M Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):458-68. PubMed ID: 21068710 [TBL] [Abstract][Full Text] [Related]
9. 175Yb-labeled hydroxyapatite: a potential agent for use in radiation synovectomy of small joints. Chakraborty S; Das T; Banerjee S; Subramanian S; Sarma HD; Venkatesh M Nucl Med Biol; 2006 May; 33(4):585-91. PubMed ID: 16720253 [TBL] [Abstract][Full Text] [Related]
10. Assessment of 186Re chelate-conjugated bisphosphonate for the development of new radiopharmaceuticals for bones. Uehara T; Jin ZL; Ogawa K; Akizawa H; Hashimoto K; Nakayama M; Arano Y Nucl Med Biol; 2007 Jan; 34(1):79-87. PubMed ID: 17210464 [TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation after 1 year of 153-samarium hydroxyapatite synovectomy in patients with haemophilic arthropathy. Calegaro JU; Machado J; DE Paula JC; DE Almeida JS; Casulari LA Haemophilia; 2009 Jan; 15(1):240-6. PubMed ID: 18976248 [TBL] [Abstract][Full Text] [Related]
12. Radiopharmaceuticals for radiation synovectomy: evaluation of two yttrium-90 particulate agents. Davis MA; Chinol M J Nucl Med; 1989 Jun; 30(6):1047-55. PubMed ID: 2738687 [TBL] [Abstract][Full Text] [Related]
13. Absorbed dose profiles for (32)P, (90)Y, (188)Re, (177)Lu, (153)Sm and (169)Er: radionuclides used in radiosynoviortheses treatment. Torres M; Ayra E; Albuerne O; Montano Delgado MA Rev Esp Med Nucl; 2009; 28(4):188-92. PubMed ID: 19922831 [TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of a new radiopharmaceutical for radiosynovectomy, 111Ag-labelled hydroxyapatite (HA) particles. Chattopadhyay S; Vimalnath KV; Saha S; Korde A; Sarma HD; Pal S; Das MK Appl Radiat Isot; 2008 Mar; 66(3):334-9. PubMed ID: 17951062 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcome after one year following samarium-153 particulate hydroxyapatite radiation synovectomy. Clunie G; Lui D; Cullum I; Ell PJ; Edwards JC Scand J Rheumatol; 1996; 25(6):360-6. PubMed ID: 8996470 [TBL] [Abstract][Full Text] [Related]
16. Samarium 153-labeled hydroxyapatite microspheres for radiation synovectomy in the horse: a study of the biokinetics, dosimetry, clinical, and morphologic response in normal metacarpophalangeal and metatarsophalangeal joints. Yarbrough TB; Lee MR; Hornof WJ; Koblik PD; Brodack J; Troup C; O'Brien TR; Pool R Vet Surg; 2000; 29(2):191-9. PubMed ID: 10730712 [TBL] [Abstract][Full Text] [Related]
17. DA-7911, 188Rhenium-tin colloid, as a new therapeutic agent of rheumatoid arthritis. Shin CY; Son M; Ko JI; Jung MY; Lee IK; Kim SH; Kim WB; Jeong JM; Song YW Arch Pharm Res; 2003 Feb; 26(2):168-72. PubMed ID: 12643596 [TBL] [Abstract][Full Text] [Related]
18. In vivo stability of ferric hydroxide macroaggregates (FHMA). Is it a suitable carrier for radionuclides used in synovectomy? Chinol M; Vallabhajosula S; Zuckerman JD; Goldsmith SJ Int J Rad Appl Instrum B; 1990; 17(5):479-86. PubMed ID: 2391243 [TBL] [Abstract][Full Text] [Related]
19. Radiation synovectomy of the ankle with 75 MBq colloidal 186rhenium-sulfide: effect, leakage, and radiation considerations. van der Zant FM; Jahangier ZN; Moolenburgh JD; van der Zee W; Boer RO; Jacobs JW J Rheumatol; 2004 May; 31(5):896-901. PubMed ID: 15124247 [TBL] [Abstract][Full Text] [Related]
20. Rhenium heptasulfide: a potential carrier system for radiation synovectomy. Venkatesan PP; Shortkroff S; Zalutsky MR; Sledge CB Int J Rad Appl Instrum B; 1990; 17(4):357-62. PubMed ID: 2387743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]